Pleural Effusion Due to Use of Pioglitazone: A Case Report

Metab Syndr Relat Disord. 2020 Apr;18(3):168-171. doi: 10.1089/met.2019.0109. Epub 2020 Feb 11.

Abstract

Background: Pioglitazone is an effective treatment option in clinical practice for managing type 2 diabetes mellitus. It is challenged by a lot of adverse effects, primarily body weight gain, peripheral edema, as well as congestive heart failure. Case Report: This is a case of a 76-year-old woman with no evidence of cardiac disease, who developed edema as well as bilateral pleural effusion after using pioglitazone. She got a weight decrease and complete resolution of the pleural effusion after stopping use of pioglitazone and rational use of diuretics. Conclusion: Common side effects of pioglitazone have been widely reported. However, little attention was drawn on pleural effusion in diabetic patients with no pre-existing heart dysfunction. In this case, we show the use of pioglitazone results in pleural effusion, with emphasis on the clinical recognition and management.

Keywords: case report; edema; pioglitazone; pleural effusion; thiazolidinedione.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diuretics / therapeutic use
  • Edema / chemically induced
  • Edema / diagnosis
  • Edema / drug therapy
  • Female
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Pioglitazone / adverse effects*
  • Pioglitazone / therapeutic use
  • Pleural Effusion / chemically induced*
  • Pleural Effusion / diagnosis
  • Pleural Effusion / diagnostic imaging
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Diuretics
  • Hypoglycemic Agents
  • Pioglitazone